Gabapentin for the treatment of recalcitrant chronic prurigo nodularis [7]

European Journal of Dermatology

Volumn 18, Issue 1, 2008, Pages 85-86

  Dereli, Tuǧrul ^a   Karaca, Nezih ^a   Inanir, Işil ^b   Öztürk, Günseli ^a  

^a EGE UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

AGED; CASE REPORT; DRUG DOSE INCREASE; DRUG RESPONSE; FEMALE; HUMAN; LETTER; RECALCITRANT CHRONIC PRURIGO NODULARIS; REMISSION; SKIN DISEASE;

AGED; AMINES; ANTI-ANXIETY AGENTS; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; PRURIGO;

EID: 38549106605     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Wallengren J. Prurigo: diagnosis and management. Am J Clin Dermatol 2004; 5: 85-95.
2. Gunal AI, Ozalp G, Yolda TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 2004; 19: 3137-9.
3. Winhoven SM, Coulson IH, Bottomley WW. Brachioradial pruritus: response to treatment with gabapentin. Br J Dermatol 2004; 150: 786-7.
4. Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol 2003; 42: 491-5.
5. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welly DF, Brown JP, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998; 29: 233-49.
6. Paus R., Schmelz M., Biro T., Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 2006; 116(5): 1174-86.
7. Dogukan A. Gabapentin-induced coma in a patient with renal failure. Hemodialysis International 2006; 10 (2): 168-9.